Compare SEER & RDZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SEER | RDZN |
|---|---|---|
| Founded | 2017 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 108.0M | 95.4M |
| IPO Year | 2020 | 2021 |
| Metric | SEER | RDZN |
|---|---|---|
| Price | $2.21 | $1.12 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | 307.1K | ★ 391.0K |
| Earning Date | 11-05-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 9.40 | ★ 72.12 |
| EPS | N/A | ★ N/A |
| Revenue | $16,578,000.00 | ★ $55,021,792.00 |
| Revenue This Year | N/A | $41.04 |
| Revenue Next Year | $20.50 | $78.38 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 16.99 | ★ 24.21 |
| 52 Week Low | $1.55 | $0.99 |
| 52 Week High | $2.41 | $2.56 |
| Indicator | SEER | RDZN |
|---|---|---|
| Relative Strength Index (RSI) | 59.22 | 40.17 |
| Support Level | $1.75 | $1.05 |
| Resistance Level | $2.30 | $1.44 |
| Average True Range (ATR) | 0.11 | 0.09 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 68.07 | 6.45 |
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.
Roadzen Inc is an insurance technology company on a mission to transform auto insurance powered by AI. Its clients comprise insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express. Geographically, the company operates in India, United States of America, United Kingdom, and China. It generates maximum revenue form India.